Literature DB >> 17459591

Age-dependent expression of VEGF isoforms and receptors in the rabbit anterior cruciate ligament.

Jochen G Hofstaetter1, Fawzy A Saad, Ilse-Gerlinde Sunk, Klaus Bobacz, Ingeborg Friehs, Melvin J Glimcher.   

Abstract

Vascular endothelial growth factor (VEGF) gene gives rise to several distinct isoforms of VEGF. Those isoforms differ in biochemical and biological properties, and it has been reported that their expression patterns are tissue and age specific as well. We investigated the expression levels of VEGF isoforms (VEGF121, VEGF165, VEGF183, VEGF189) and its receptors (VEGFR-1, flt-1 and VEGFR-2, flk-1/KDR) in the anterior cruciate ligament (ACL) of 2- to 3-week-, 2-month-, and 18-month-old New Zealand White rabbits using Sybr green Real-Time RT-PCR. VEGF isoforms and both receptors were expressed in the ACL at all investigated ages. VEGF121 was found to be the most abundant isoform at the ages under investigation, followed by VEGF165, VEGF189 and VEGF183. All isoforms showed decreased expression levels with age, however the larger membrane bound isoforms, VEGF183 and VEGF189, showed the most striking age-associated decrease in expression level. VEGFR-1 expression levels increased with age, while the expression level of VEGFR-2 expression was highest at 2-3 weeks and was significantly lower at 2 and 18 months of age. Distinct age-associated differences in the expression level of VEGF isoforms as well as their receptors suggest differential physiological functions during development, maturation and ageing of the ACL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459591     DOI: 10.1016/j.bbagen.2007.02.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  VEGF receptor mRNA expression by ACL fibroblasts is associated with functional healing of the ACL.

Authors:  Patrick Vavken; Fawzy A Saad; Braden C Fleming; Martha M Murray
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-02-19       Impact factor: 4.342

2.  Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage.

Authors:  C H Evans; F-J Liu; V Glatt; J A Hoyland; C Kirker-Head; A Walsh; O Betz; J W Wells; V Betz; R M Porter; F A Saad; L C Gerstenfeld; T A Einhorn; M B Harris; M S Vrahas
Journal:  Eur Cell Mater       Date:  2009-12-31       Impact factor: 3.942

3.  Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis.

Authors:  Wen-Qi Ma; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  BMC Med Genet       Date:  2018-07-04       Impact factor: 2.103

Review 4.  Molecular diversity of VEGF-A as a regulator of its biological activity.

Authors:  Jeanette Woolard; Heather S Bevan; Steven J Harper; David O Bates
Journal:  Microcirculation       Date:  2009-06-01       Impact factor: 2.628

5.  The Effect of Significant Exercise Modalities, Gender and Age on 9 Markers (Indicators) in NHISS Registered ACL Patients for Designing Exercise Intervention Program.

Authors:  Hyunseok Jee; Sae Yong Lee
Journal:  Iran J Public Health       Date:  2020-05       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.